Talk about biting the hand that feeds you. Puerto Rico, long home to pharmaceutical manufacturing facilities, has just passed a new law (Law 154) that imposes “special taxes” on non-resident companies. That means all of the “Big Pharma” firms doing business on the island.
According to a 2006 survey, the biopharma sector supports over 94,000 jobs in Puerto Rico and conducted 425 clinical trials on the island commonwealth.
It should also be noted that Law 154 was enacted minus any public input or comment.
Adios.
